ResMed Inc. vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? ResMed Inc. trades at $222.72 (market cap $32.61B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. The key difference: ResMed Inc. pays a 1.17% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and ResMed Inc. is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| RMD | USIG | |
|---|---|---|
Market Cap | $32.61B | — |
Sector | Health | Fixed Income |
52-Week High | $293.73 | $52.69 |
52-Week Low | $182.82 | $50.18 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.17% | — |
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →